首页 | 本学科首页   官方微博 | 高级检索  
     

Shenzhu Guanxin Recipe Granules (参术冠心方颗粒) for Improving Exercise Tolerance in Patients with Stable Angina (SERIES Trial): A Protocol of Multicenter,Randomized, Double-Blind,Placebo Parallel Controlled Clinical Trial
作者姓名:MAO Shuai  XU Dan-ping  DANG Xiao-jing  LI Winny  WU Huan-lin
作者单位:Second Clinical Medical College;Heart Center;Faculty of Medicine;Beijing University of Chinese Medicine
基金项目:Supported by Foundation from Department of Science and Technology of Guangdong Province(No.2012A032500017);Foundation from Guangdong Provincial Academy of Traditional Chinese Medicine(No.YN2014LN07,YK2013B1N10,A2016192);Science Foundation of Guangdong Province(No.2015A030310437,2015A030306049);National Natural Science Foundation(No.81403341,81703877)
摘    要:Background:Manypatientswithchronicanginaexperienceanginalepisodesdespitesuccessfulrecanalization,antianginalandantiischemicmedications.EmpiricalobservationssuggestedthatShenzhuGuanxinRecipeGranules(参术冠心方颗粒,SGR),aChineseherbalcompound,exertedpotentialimpactsonincreasedtreadmillexerciseperformanceandanginarelieve.However,therehasbeennosystematicstudytoclarifytheimpactofSGRonexercisetoleranceinpatientswithstableangina.TheSERIES(ShEnzhuguanxinRecipeforImprovingExercisetoleranceinpatientswithStableangina)trialisdesignedtodeterminetheeffectsofSGRonexerciseduration,electrocardiographic(ECG)evidenceofmyocardialischemia,andincidenceofmajoradversecardiacevents(MACE)instableanginalpatients.Methods:Atotalof184eligiblepatientswithstableanginawillberandomlyassignedtoreceiveplaceboorSGR(10g/dayfor12weeks)ina1:1ratio.Theprimaryoutcomewillbethechangefrombaselineintotalexercisetoleranceduration,timetoonsetofanginaandECGischemiaduringexercisetreadmilltestingperformedovera12-weekstudyperiod.ThesecondaryoutcomewillincludeECGmeasures,theoccurrenceandcompositeofMACEandtheSeattleAnginaQuestionnairescore.Moreover,thecoronarymicrocirculationwillbeevaluatedtoexplorethepossibleeffectsinresponsetotreatmentofSGR.Aftertheprocedure,allparticipantswillbefollowedupbyinterviewat3and6months,enquiringaboutanycardiacevents,hospitalizations,cardiacfunctionallevelandmedicationusage.Additionally,theoccurrenceofadverseeventswillbeevaluatedateachfollow-up.Discussion:ThisstudymayprovidenovelevidenceontheefficacyofSGRinimprovingexercisetoleranceandpotentiallyreducingclinicaladverseevents.(TrialregistrationNo.ChiCTR-TRC-14004504)

关 键 词:exercise  tolerance  stable  angina  Shenzhu  Guanxin  RECIPE  coronary  microcirculation  TRIAL  PROTOCOL  RANDOMIZED  controlled  TRIAL
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国结合医学杂志》浏览原始摘要信息
点击此处可从《中国结合医学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号